Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

Share Price is delayed by 15 minutes
Get Live Data
1,531.00    0.00 (0.00%)
Bid:
1,100.00
Ask:
2,200.00
Spread: 1,100.00 (100.00%)
Market Cap: £3.22b
HIK Live PriceLast checked at - London Stock Exchange

Intraday Hikma Pharmaceuticals Share Chart

Hikma Pharmaceuticals News

UK WINNERS & LOSERS SUMMARY: Pharmaceutical Firms Rally
4 Nov 2020

UK WINNERS & LOSERS SUMMARY: Pharmaceutical Firms Rally

UK WINNERS & LOSERS SUMMARY: Pharmaceutical Firms Rally

UK Earnings, Trading Statements Calendar - Next 7 Days
29 Oct 2020

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Hikma Pharmaceuticals Expands US Collaboration With Arecor
20 Oct 2020

Hikma Pharmaceuticals Expands US Collaboration With Arecor

Hikma Pharmaceuticals Expands US Collaboration With Arecor

UK BROKER RATINGS SUMMARY: Goldman Raises Coca-Cola HBC And Cuts DCC
1 Oct 2020

UK BROKER RATINGS SUMMARY: Goldman Raises Coca-Cola HBC And Cuts DCC

UK BROKER RATINGS SUMMARY: Goldman Raises Coca-Cola HBC And Cuts DCC

IN BRIEF: Vectura Notes Hikma's Advair US Regulatory Setback
22 Sep 2020

IN BRIEF: Vectura Notes Hikma's Advair US Regulatory Setback

IN BRIEF: Vectura Notes Hikma's Advair US Regulatory Setback

LONDON MARKET CLOSE: Stocks Rebound Slightly As Covid-19 Fears Remain
22 Sep 2020

LONDON MARKET CLOSE: Stocks Rebound Slightly As Covid-19 Fears Remain

LONDON MARKET CLOSE: Stocks Rebound Slightly As Covid-19 Fears Remain

UK WINNERS & LOSERS SUMMARY: Beazley's Virus Claims Estimate Doubles
22 Sep 2020

UK WINNERS & LOSERS SUMMARY: Beazley's Virus Claims Estimate Doubles

UK WINNERS & LOSERS SUMMARY: Beazley's Virus Claims Estimate Doubles

Hikma Expects To Gain FDA Approval For Advair Diskus In Early 2021
22 Sep 2020

Hikma Expects To Gain FDA Approval For Advair Diskus In Early 2021

Hikma Expects To Gain FDA Approval For Advair Diskus In Early 2021